EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger

Youssouf Kabore, Renaud Vatrinet, Ousmane Guindo, Souleymane H Moussa, William H K Schilling, Rebecca F Grais

The American Journal of Tropical Medicine and Hygiene · 2023

DOI: 10.4269/ajtmh.22-0606 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Youssouf Kabore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Epicentre Niger, Niamey, Niger. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a rapidly emerging virus causing the coronavirus disease 2019 (COVID-19) pandemic, had no known effective prophylaxis and no widely available proven effective antiviral treatment. Hydroxychloroquine/Chloroquine was identified as an early potential therapeutic candidate drawing on evidence from reports of both in vitro and in vivo testing. A multicountry placebo-controlled randomized trial was set to evaluate the use of hydroxychloroquine/chloroquine to prevent infection in healthcare workers and staff working in a health facility involved in COVID-19 management. One of the sites of this trial was in Niger. In Niger, of the 240 persons who were provided information about the study and with whom participation was discussed, only five participants provided their informed consent. In this article, we describe the key difficulties encountered in the conduct of this trial from the perspective of the site study team. Among the difficulties, we recognize that the epidemic context, controversy surrounding hydroxychloroquine, vaccine rollout, participants’ perspectives, and trial design had a major impact on participation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansHydroxychloroquineSARS-CoV-2NigerCOVID-19 Drug TreatmentAntiviral AgentsHealth Personnel

Substanzen

HydroxychloroquineAntiviral Agents

Autor:innen und Institutionen

  • Epicentre Niger, Niamey, Niger.
  • Research Department, Epicentre Paris, Paris, France.
  • Service de Pneumologie, Hôpital National Amirou Boubacar Diallo (Lamorde), Niamey, Niger.
  • Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Zitieren

APA

Kabore, Y., Vatrinet, R., Guindo, O., Moussa, S. H., Schilling, W. H. K., & Grais, R. F. (2023). Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0606

Vancouver

Kabore Y, Vatrinet R, Guindo O, Moussa SH, Schilling WHK, Grais RF. Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.22-0606

BibTeX
@article{Kabore2023,
  author = {Kabore, Youssouf and Vatrinet, Renaud and Guindo, Ousmane and Moussa, Souleymane H and Schilling, William H K and Grais, Rebecca F},
  title = {Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.4269/ajtmh.22-0606}
}
Kostenlos starten →